Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Epigallocatechin 3-gallate inhibits 7-ketocholesterol-induced monocyte-endothelial cell adhesion.

Yamagata K, Tanaka N, Suzuki K.

Microvasc Res. 2013 Jul;88:25-31. doi: 10.1016/j.mvr.2013.03.006. Epub 2013 Apr 6.

PMID:
23567873
2.

β-carotene reverses the IL-1β-mediated reduction in paraoxonase-1 expression via induction of the CaMKKII pathway in human endothelial cells.

Yamagata K, Tanaka N, Matsufuji H, Chino M.

Microvasc Res. 2012 Nov;84(3):297-305. doi: 10.1016/j.mvr.2012.06.007. Epub 2012 Jun 29.

PMID:
22750393
3.

Epigallocatechin-3-gallate inhibits VCAM-1 expression and apoptosis induction associated with LC3 expressions in TNFα-stimulated human endothelial cells.

Yamagata K, Xie Y, Suzuki S, Tagami M.

Phytomedicine. 2015 Apr 15;22(4):431-7. doi: 10.1016/j.phymed.2015.01.011. Epub 2015 Feb 21.

PMID:
25925964
4.
5.
6.

7-Ketocholesterol enhances the expression of adhesion molecules on human aortic endothelial cells by increasing the production of reactive oxygen species.

Shimozawa M, Naito Y, Manabe H, Uchiyama K, Kuroda M, Katada K, Yoshida N, Yoshikawa T.

Redox Rep. 2004;9(6):370-5.

PMID:
15720835
7.
8.

(-)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-kappaB signaling.

Hong MH, Kim MH, Chang HJ, Kim NH, Shin BA, Ahn BW, Jung YD.

Life Sci. 2007 May 1;80(21):1957-65. Epub 2007 Feb 27.

PMID:
17379255
9.

Azelnidipine, a new calcium channel blocker, inhibits endothelial inflammatory response by reducing intracellular levels of reactive oxygen species.

Naito Y, Shimozawa M, Manabe H, Nakabe N, Katada K, Kokura S, Yoshida N, Ichikawa H, Kon T, Yoshikawa T.

Eur J Pharmacol. 2006 Sep 28;546(1-3):11-8. Epub 2006 Jul 25.

PMID:
16919261
11.

(-)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells.

Li J, Ye L, Wang X, Liu J, Wang Y, Zhou Y, Ho W.

J Neuroinflammation. 2012 Jul 6;9:161. doi: 10.1186/1742-2094-9-161.

12.

Inhibitory effect of delphinidin on monocyte-endothelial cell adhesion induced by oxidized low-density lipoprotein via ROS/p38MAPK/NF-κB pathway.

Chen CY, Yi L, Jin X, Zhang T, Fu YJ, Zhu JD, Mi MT, Zhang QY, Ling WH, Yu B.

Cell Biochem Biophys. 2011 Nov;61(2):337-48. doi: 10.1007/s12013-011-9216-2.

PMID:
21695376
13.

Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells.

Ahn HY, Xu Y, Davidge ST.

Life Sci. 2008 Apr 23;82(17-18):964-8. doi: 10.1016/j.lfs.2008.02.018. Epub 2008 Mar 8.

PMID:
18397796
14.

Ginkgo biloba extract reduces high-glucose-induced endothelial reactive oxygen species generation and cell adhesion molecule expression by enhancing HO-1 expression via Akt/eNOS and p38 MAP kinase pathways.

Tsai HY, Huang PH, Lin FY, Chen JS, Lin SJ, Chen JW.

Eur J Pharm Sci. 2013 Mar 12;48(4-5):803-11. doi: 10.1016/j.ejps.2013.01.002. Epub 2013 Jan 26.

PMID:
23357604
15.

Protective effects of (-)-epigallocatechin-3-gallate against TNF-α-induced lung inflammation via ROS-dependent ICAM-1 inhibition.

Lee IT, Lin CC, Lee CY, Hsieh PW, Yang CM.

J Nutr Biochem. 2013 Jan;24(1):124-36. doi: 10.1016/j.jnutbio.2012.03.009. Epub 2012 Jul 21.

PMID:
22819551
16.

Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro.

Melgarejo E, Medina MA, Sánchez-Jiménez F, Urdiales JL.

Br J Pharmacol. 2009 Dec;158(7):1705-12. doi: 10.1111/j.1476-5381.2009.00452.x. Epub .

19.

EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling.

Ou HC, Song TY, Yeh YC, Huang CY, Yang SF, Chiu TH, Tsai KL, Chen KL, Wu YJ, Tsai CS, Chang LY, Kuo WW, Lee SD.

J Appl Physiol (1985). 2010 Jun;108(6):1745-56. doi: 10.1152/japplphysiol.00879.2009. Epub 2010 Mar 4.

20.

Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions.

Zhang Q, Jiang Y, Toutounchian JJ, Soderland C, Yates CR, Steinle JJ.

Mol Vis. 2013 Apr 5;19:796-803. Print 2013.

Items per page

Supplemental Content

Write to the Help Desk